Genomics of Diabetes: Functional characterisation of T2D GWAS
Dr A Gloyn
26 July 2019
Diabetes already affects 415 million people worldwide. In the UK, there will be 5M people with type 2 diabetes (T2D) by 2025, accounting for 1 in 30 prescriptions and £25 billion in annual NHS costs.
Targeting BETA-Cell Failure in Lean Patients With Type 2 Diabetes
Dr E Levelt, Prof S Plein
15 April 2019
Heart failure is a major health concern in patients with type 2 diabetes. While the focus of prevention in type 2 diabetes is on obesity, many people with type 2 diabetes are not overweight and it is poorly understood why lean people develop type 2 diabetes and how exactly this should be addressed.
Health Opportunity for Patient Empowerment in Gestational Diabetes (HOPE-GDM)
Chemistry and Biosciences
Prof A M Graham, Prof R Qahwaji, Prof A Locke
Applications accepted all year round
Gestational Diabetes is a temporary condition diagnosed at 24-28 weeks gestation, where the body is unable to maintain normal blood glucose levels due to insulin resistance during pregnancy.